New Partnership with IDA Ireland Bolsters Cerner's Commitment to Drive Innovation and Advance Population Health Intelligence

CernerCerner has announced the plans to significantly grow its Dublin hub for research and development. Working with the support of the Irish Government through IDA Ireland, will be created 50 new roles focused on R&D and the improvement of data intelligence and population health management for the European clients.

The expertise and innovation Cerner will build in Ireland will initially focus on developing advanced predictive algorithms to run on the population health intelligence platform, HealtheIntentSM, and help the clients proactively manage health and improve the wellbeing of their communities. These advancements enable a shift from reactive care to proactive health, supporting health and care professionals to take appropriate preventative actions that can keep patients out of the hospitals, reduce morbidity, and encourage citizens to take ownership over the management of their health.

The expansion in Ireland reaffirms Cerner’s commitment to invest and contribute to Ireland's growth by developing local expertise and creating a research infrastructure that can then be leveraged for future projects. It also highlights the rapid growth of the industry-leading population health management tools and services around the globe.

Cerner will create 50 new research and development job positions to join the Dublin-based Intellectual Property (IP) development team over the next five years. New roles to be recruited include software engineers, software architects, designers and data visualisation developers, with different levels of knowledge and experience. Successful candidates will gain a variety of skills and receive training on relevant technology tools including different programming languages, big data and Internet of Things (IoT) technologies, and the Agile Software Development methodology.

Speaking about the announcement, Ireland’s Minister for Business, Enterprise & Innovation, Heather Humphreys TD said: "I am delighted to see Cerner expand its Dublin operation with the creation of 50 high quality R&D jobs. This is an exciting announcement, which enhances Ireland’s capability in the healthcare IT sector. I wish the company every success in the exciting times ahead."

Matthew Pickett, Senior Director and General Manager for Cerner Ireland, said: "Cerner have had a permanent presence in Ireland since 2007, supporting our global clients in the transformation of health and care services and the improvement of their populations' wellbeing. When seeking a European location in which to further build upon Cerner’s rapidly growing capabilities in Population Health Management, the expansion of our existing Dublin team was a natural step.

"Projects resulting from this new investment, supported by IDA Ireland, will enable the delivery of smarter, better care for citizens and healthier populations across the globe."

Senior Director for Population Health in Europe, Aiden Malone, added: "Population health is about taking responsibility for managing the overall health and wellbeing of a defined population and being accountable for the health outcomes of that population. It’s about how we can move from treating conditions to preventing them from happening in the first place. The expansion of our R&D team in Dublin will allow us to develop new intelligence on our HealtheIntentSM platform and continue to enable the shift to value-based care for populations through delivering outcomes one person at a time.

"We are looking forward to partnering with companies, academic institutions, and the thriving innovation scene in the Irish ecosystem to bring together research and development in areas of medical technology, pharmaceutical, big data & analytics, advanced technology and the focus area of IoT. These elements are key components of delivering Population Health Management and will have a direct impact on improving outcomes of millions of lives."

Welcoming the announcement, Mary Buckley, Executive Director for IDA Ireland, said "Cerner is a high-profile company and leader in the healthcare IT market. This investment by Cerner is ambitious in scope and addresses pressing future challenges in healthcare. It will enrich Ireland’s capability in the key technology areas of big data management and processing. This investment also provides an excellent reference point for IDA in convergence technologies."

About IDA Ireland

Ireland's inward investment promotion agency, the IDA, is a non-commercial, semi-state body promoting Foreign Direct Investment into Ireland through a wide range of services.

By establishing partnerships with potential and existing investors to help them establish or expand their operations in Ireland, the agency has evolved to become a global force in attracting FDI to Ireland and a key influencer in the development of the Irish economy and its reputation abroad.

About Cerner

At Cerner, we believe in building positive, long-term partnerships that drive value across the health and care landscape. Our intelligent platforms and services connect people, information and care at 27,000+ facilities of all sizes worldwide and help manage the health of 110 million citizens across the globe. Together with clients and industry partners, we’re innovating for the future, integrating entire health and care systems to enable them to deliver smarter, value-based care, better outcomes, and proactively manage and improve the wellbeing of their populations.

In Ireland, we are working in partnership with the HSE to implement our Millennium® EHR platform at 19 maternity sites across the country as part of the Maternal & Newborn Clinical Management System (MN-CMS) project. This will help the HSE to provide every mother and child with world-class standards of health and care through a single electronic health record platform with accurate, accessible and secure data. Likewise, our laboratory solutions are contracted through the MedLIS programme to connect all 43 HSE-funded laboratories nationwide and link them to the clinical community with a single national electronic laboratory record. This will ensure greater access to patients’ laboratory history and data, a reduction in test duplication, and improved efficiency and outcomes for Irish citizens.

Cerner's mission is to contribute to the systemic transformation of health care delivery and the health of communities. Nasdaq: CERN.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...